Human CD20 Monoclonal Antibody
Produktgrößen
1 mg
£355,00
YR0130-1MG
5 mg
£885,00
YR0130-5MG
20 mg
£2835,00
YR0130-20MG
Über dieses Produkt
- SKU:
- YR0130
- Zusätzliche Namen:
- B1|Bp35|CD20|CVID5|FMC7|LEU-16|MS4A1|S7
- Anwendung:
- Block/Inhibit/Neutralise, Cell-based/Functional Assay, ELISA
- Klonalität:
- Monoclonal
- Weitere Details:
- Obinutuzumab is an antineoplastic CD20 antibody used to treat untreated chronic lymphocytic leukemia in combination with chlorambucil.In contrast to rituximab, which is a classic type I CD20 antibody, obinutuzumab binds to type II CD20 antibodies. This allows obinutuzumab to have a much higher induction of antibody-dependant cytotoxicity and a higher direct cytotoxic effect than the classic CD20 antibodies.
- Formulierung:
- Purified from cell culture supernatant in an animal-free facility
- Immunogen:
- Human CD20
- Isotyp:
- IgG1, kappa
- Molekulargewicht:
- 150 kDa
- Reinheit:
- >95%
- Versandbedingungen:
- Blue Ice
- Lagerbedingungen:
- 2-8[o]C Avoid freeze/thaw cycles., -70[o]C Avoid freeze/thaw cycles.
- Hersteller:
- ABclonal Technology
- Typ:
- Antibody: Biosimilar Antibody
- Datenblatt des Herstellers:YR0130